MetLife Investment Advisors »

Fennec Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $100k 13k 7.70
2025-09-30 $90k 9.6k 9.36
2025-06-30 $126k 15k 8.30
2025-03-31 $73k 12k 6.09
2024-12-31 $99k 16k 6.32
2024-06-30 $28k 4.5k 6.11
2023-12-31 $109k 9.7k 11.22
2023-09-30 $73k 9.7k 7.51
2023-06-30 $86k 9.7k 8.83
2020-06-30 $95k 11k 8.35